M+PAC®

Pharmaceutical Name
Mycoplasma hyopneumoniae Bacterin
Features and Benefits
- Protects against mycoplasma pneumonia - one of the most economically significant disease-associated conditions in swine production.
- In tests conducted by independent research facilities, M+PAC - vaccinated pigs demonstrated:
- higher antibody titers
- numerically lower lung lesion scores
- less coughing
- numerically higher cell-mediated immunity
- Contains safe and smooth Emunade® for:
- Faster acting, longer lasting protection
- Less tissue reaction
- Excellent syringeability
- Easy on pigs
- Can be used in both one and two dose programs
- 4 month duration of immunity
- Can be used in pigs with moderate maternal antibody titers to M. hyo.
Indications
For use as an aid in the prevention of pneumonia caused by Mycoplasma hyopneumoniae infection in swine. For herds that use a single dose program, vaccinate pigs subcutaneously or intramuscularly at six weeks of age or older with a single 2 mL dose. For herds that use a two dose program, vaccinate pigs intramuscularly with 1 mL of M+PAC at 7-10 days of age or older. Give a booster dose of 1 mL two weeks later.
WARNING: Extreme caution should be used when injecting any oil emulsion vaccine to avoid injecting your own finger or hand. Accidental injection can cause serious local reaction. Contact a physician immediately if accidental injection occurs.
Dosage
For further information including dose rate and complete directions and warnings, please see the Product Label by clicking here.
M+PAC is a registered trademark of Schering-Plough Animal Health Corporation.
Species
